• Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Top Trading Strategy
No Result
View All Result
Home Breaking News

Biden expected to pick former FDA Commissioner Dr. Robert Califf to run the agency

by
November 12, 2021
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Related Posts

Here’s where to invest $10,000 right now, according to the pros

Jamie Dimon is being deposed over JPMorgan Chase role in Epstein lawsuits

IHOP overhauls its menu: Cinn-A-Stack pancakes are back, savory crepes are in

Bitcoin climbs 5% above $28,000 as investors shrug off regulatory crackdowns

Dr. Robert Califf testifies during his nomination hearing before the Senate Health, Education, Labor and Pensions Committee November 17, 2015 in Washington, DC.

Win McNamee | Getty Images

President Joe Biden is expected to pick Dr. Robert Califf to serve as the chief of the Food and Drug Administration, NBC News reported Friday, citing people familiar with the selection process.

The FDA, currently overseen by acting Commissioner Dr. Janet Woodcock, has been without a permanent chief since Biden took office in January. The White House reportedly ruled out Woodcock after she faced opposition from some members of Congress over her handling of opioids while at the agency.

Califf, a cardiologist who works at the Duke University School of Medicine, was briefly the agency’s commissioner under the Obama administration beginning in 2016. He also served as deputy commissioner of the FDA’s medical products and tobacco office.

The new selection is expected imminently because Woodcock cannot legally stay on as the acting head past Nov. 15 without a nominee to hold the position permanently.

Biden’s expected nomination comes amid the ongoing Covid-19 pandemic, which has killed at least 759,678 Americans, according to data compiled by Johns Hopkins University.

The FDA has helped bring lifesaving treatments to the market and authorized the use of Covid vaccines, which have shown to be highly effective, especially against severe disease, hospitalization and death.

More than 194 million Americans are fully vaccinated against Covid, according to data compiled by the Centers for Disease Control and Prevention.

The FDA has recently come under harsh criticism, though, over its decision to approve Biogen’s Alzheimer’s drug, Aduhelm.

Next Post

Why This IBM Spinoff Is Struggling

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Breaking News

Here’s where to invest $10,000 right now, according to the pros

by
March 29, 2023
0

Markets have been hit by volatility over the past month leading some retail investors to question where to park their...

Read more

Here’s where to invest $10,000 right now, according to the pros

Jamie Dimon is being deposed over JPMorgan Chase role in Epstein lawsuits

IHOP overhauls its menu: Cinn-A-Stack pancakes are back, savory crepes are in

Bitcoin climbs 5% above $28,000 as investors shrug off regulatory crackdowns

Mortgage demand gets a boost from bank volatility, but it may be short-lived

Goldman Sachs says this energy stock is undervalued and poised for strong gains

Load More

All rights reserved by www.toptradingstrategy.net

  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.